There is no cure for herpes, but effective treatments exist that can shorten outbreaks, reduce their frequency by 70% to 80%, and lower the risk of passing the virus to a partner. Most people with herpes use one of three prescription antiviral medications, either during outbreaks or as a daily pill, and many go long stretches without symptoms at all.
How Antiviral Medications Work
Three prescription antivirals are the backbone of herpes treatment: acyclovir, valacyclovir, and famciclovir. All three work by blocking the virus’s ability to copy itself inside your cells. They don’t eliminate the virus from your body, but they slow it down enough that your immune system can keep outbreaks shorter, less severe, and less frequent.
These medications come in pill form and are taken by mouth. Your provider will typically choose one based on dosing convenience and cost. Valacyclovir, for instance, requires fewer daily doses than acyclovir, which makes it easier for many people to stick with. Side effects are generally mild, and these drugs have decades of safety data behind them.
Episodic vs. Daily Treatment
You and your provider will choose between two strategies depending on how often you have outbreaks and your personal goals.
Episodic therapy means taking antivirals only when you feel an outbreak coming on. You start the medication at the first sign of symptoms, such as tingling, itching, or redness, and continue for a short course (typically a few days). This approach works well if you have infrequent outbreaks, perhaps a few times a year or less. The earlier you start, the more effectively the medication shortens the episode.
Suppressive therapy means taking a low dose of an antiviral every single day, whether or not you have symptoms. This is the stronger option. Suppressive therapy reduces outbreak frequency by 70% to 80% in people who have frequent recurrences. Many people on daily therapy go a year or more without a single outbreak. It also reduces viral shedding, which is when the virus is present on the skin without visible sores. That makes it a key tool for protecting sexual partners. Daily valacyclovir has been shown to decrease the rate of HSV-2 transmission in couples where one partner has genital herpes, particularly when combined with condom use and avoiding sex during active outbreaks.
If you’re having six or more outbreaks a year, suppressive therapy is the usual recommendation. But even people with fewer outbreaks sometimes choose daily treatment for the peace of mind it provides or to reduce transmission risk in a relationship.
Over-the-Counter Options for Cold Sores
For oral herpes (cold sores), an over-the-counter cream called docosanol is available without a prescription. It works differently from prescription antivirals: rather than targeting the virus’s replication, it helps prevent the virus from entering healthy skin cells. You apply it to the affected area five times a day until the sore heals.
Docosanol won’t cure the infection, but it can reduce pain and discomfort and help sores heal faster. The catch is timing. It works best when applied at the very first sign of a cold sore, before blisters fully form. If you wait until sores are well established, the benefit drops significantly. For people who get frequent or severe cold sores, prescription antivirals are more effective than any topical option.
Reducing Transmission Risk
One of the biggest reasons people seek treatment isn’t just symptom relief. It’s protecting a partner. Herpes can spread even when no sores are visible because the virus periodically “sheds” from the skin without causing noticeable symptoms. People with a history of symptomatic genital herpes shed the virus roughly twice as often as those who carry HSV-2 without knowing it.
The most effective strategy for reducing transmission combines three things: daily suppressive antiviral therapy, consistent condom use, and avoiding sexual contact during active outbreaks. No single measure eliminates risk entirely, but layering these approaches together brings the transmission rate down substantially. The CDC recommends that couples where one partner has genital HSV-2 consider suppressive therapy as part of their prevention plan.
What Happens Over Time
Herpes outbreaks tend to become less frequent and less severe on their own as the years pass. The first outbreak is almost always the worst, often lasting two to four weeks with more painful sores. Recurrences after that are usually shorter and milder. Some people stop having noticeable outbreaks entirely after the first few years, even without daily medication.
This natural decline means your treatment needs may change over time. Someone who starts on daily suppressive therapy might eventually switch to episodic treatment, or stop medication altogether if outbreaks become rare. It’s worth revisiting your approach with a provider every year or two.
Progress Toward a Cure
The reason herpes can’t be cured with current drugs is that the virus hides in clusters of nerve cells, where it stays dormant between outbreaks. Antivirals can only target the virus when it’s actively replicating, not when it’s sitting quietly in those nerve cells.
Researchers at Fred Hutch Cancer Center are working on a gene therapy approach designed to solve that exact problem. Their experimental treatment uses a specially engineered vector (a delivery vehicle) injected into the bloodstream that travels to the nerve clusters where herpes hides. Once there, it delivers molecular scissors called meganucleases that cut the virus’s DNA in two places, damaging it beyond repair. The body’s own repair systems then recognize the broken DNA as foreign and clear it out.
In mouse studies, this approach eliminated 90% of HSV-1 after oral infection and 97% after genital infection. The team has also simplified the therapy from three vectors and two different cutting enzymes down to just one of each, making it more practical for eventual human use. They are now working with regulatory partners to prepare for clinical trials, though no timeline for human testing has been announced. The current research focuses on HSV-1, with work underway to adapt the technology for HSV-2.
On the vaccine front, Moderna is running a Phase 1/2 clinical trial of an mRNA-based therapeutic vaccine (mRNA-1608) in roughly 300 adults with recurrent genital HSV-2. This vaccine is designed to treat people who already have herpes, not just prevent new infections. Interim results have been reported, but the trial is still ongoing, and no vaccine is close to market availability yet.
Living With Herpes Between Outbreaks
Beyond medication, a few practical factors influence how often outbreaks happen. Stress, illness, fatigue, sun exposure, and hormonal changes (like menstruation) are common triggers. You can’t always avoid these, but recognizing your personal patterns helps. Some people notice that outbreaks cluster around periods of high stress or poor sleep, and managing those factors can make a measurable difference alongside medication.
Keeping the affected area clean and dry during an outbreak helps sores heal. Wearing loose-fitting clothing reduces irritation. Cool compresses or over-the-counter pain relievers can manage discomfort. These aren’t treatments for the virus itself, but they make outbreaks easier to get through.